Address:

4401 Varsity Drive, Suite E , Ann Arbor , MI , USA 48108

Telephone:

734 973 7914

Fax:

734 973 7932

Email:

info@nextgensciences.com

Website:

www.nextgensciences.com

Biomarker testing services provider

Chief Executive:

Klaus Rosenau (12.7% holding)

Finance Director:

Leif Hamo (0% holding)

Non-Exec Director:

Thomas Borcholte (0% holding)

Zeus: 19.7%

The Create East of England Partnership: 16.2%

Perfekt Beteiligungsmanagement: 11.1%

Private Life Partners: 9.2%

Patrick Rhatigan*: 3.9%

Nominated Adviser:

Seymour Pierce

Nominated Broker:

Astaire Securities

Solicitors:

Fasken Martineau

Auditors:

Grant Thornton

Registrar:

Capita Registrars

Entry on AIM:

30/12/2005

Issue Price:

3.0p

Interim Results:

Sep

Final Results:

Apr

Year End:

Dec

Accounts Due:

n/a

Int div payment:

n/a

Fin div payment:

n/a

Int net div per share:

nil

Fin net div per share:

nil

	2009	2008
Turnover:	$1.16m	$1.20m
Pre-tax profit:	$ (4.49m)	$ (2.75m)
EPS:	(0.11) c	(0.16) c